XML 18 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating activities:        
Net loss $ (4,185) $ (6,200) $ (12,919) $ (14,871)
Adjustments to reconcile net loss to net cash used in operating activities:        
Amortization of deferred issuance costs 8 355 8 402
Unrealized loss/(gain) on securities (39)   (137)  
Stock-based compensation - consultants   21 9 63
Stock-based compensation - employees 917 1,238 2,830 2,151
Changes in operating assets and liabilities:        
Prepaid expenses (823) (734) (435) (674)
Other assets (2)     4
Accounts payable 477 (71) (417) 1,072
Accrued liabilities 689 (55) 84 (458)
Net cash used in operating activities (2,958) (5,446) (10,977) (12,311)
Financing activities:        
Issuance of shares, options exercise     24  
Issuance of shares, net of issuance costs       31,967
Long-term debt     5,000  
Debt discount     (14)  
Capitalized deferred issuance costs   (117) (42) (140)
Net cash provided by financing activities   (117) 4,968 31,827
Increase/(decrease) in cash and cash equivalents (2,958) (5,563) (6,009) 19,516
Cash and cash equivalents - Beginning of period 27,293 38,729 30,344 13,650
Cash and cash equivalents - End of period $ 24,335 $ 33,166 $ 24,335 33,166
Non-cash investing and financing activities:        
Deferred issuance cost (warrant value)       $ 255